251 related articles for article (PubMed ID: 19233086)
1. Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.
Jacobs MA; Pan L; Macura KJ
Semin Roentgenol; 2009 Apr; 44(2):111-22. PubMed ID: 19233086
[No Abstract] [Full Text] [Related]
2. Preliminary application of whole body diffusion weighted imaging in screening metastasis.
Guan YJ; Ling HW; Chen KM
Chin Med Sci J; 2008 Sep; 23(3):178-82. PubMed ID: 18853854
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
Li B; Li Q; Nie W; Liu S
Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study of feasibility of whole body diffusion weighted imaging in diagnosis of metastasis of tumor.
Yang TH; Lin JZ; Wang X; Lu JH; Chen Z
Chin Med Sci J; 2008 Sep; 23(3):187-92. PubMed ID: 18853856
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases.
Gu TF; Xiao XL; Sun F; Yin JH; Zhao H
Chin Med Sci J; 2008 Sep; 23(3):145-50. PubMed ID: 18853848
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.
Jacobs MA; Ouwerkerk R; Petrowski K; Macura KJ
Top Magn Reson Imaging; 2008 Dec; 19(6):261-72. PubMed ID: 19512848
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR imaging for whole body metastatic disease and lymphadenopathy.
Low RN
Magn Reson Imaging Clin N Am; 2009 May; 17(2):245-61. PubMed ID: 19406357
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla.
Mürtz P; Krautmacher C; Träber F; Gieseke J; Schild HH; Willinek WA
Eur Radiol; 2007 Dec; 17(12):3031-7. PubMed ID: 17646990
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.
Han SN; Amant F; Michielsen K; De Keyzer F; Fieuws S; Van Calsteren K; Dresen RC; Gziri MM; Vandecaveye V
Eur Radiol; 2018 May; 28(5):1862-1874. PubMed ID: 29218610
[TBL] [Abstract][Full Text] [Related]
11. Whole-body diffusion-weighted magnetic resonance imaging.
Kwee TC; Takahara T; Ochiai R; Katahira K; Van Cauteren M; Imai Y; Nievelstein RA; Luijten PR
Eur J Radiol; 2009 Jun; 70(3):409-17. PubMed ID: 19403255
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
[TBL] [Abstract][Full Text] [Related]
13. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
Li S; Sun F; Jin ZY; Xue HD; Li ML
J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
[TBL] [Abstract][Full Text] [Related]
14. [Whole-body diffusion-weighted magnetic resonance imaging in oncology].
Jouvet JC; Thomson V; Durupt F; Bakir M; Berthezene Y
Presse Med; 2010 May; 39(5):548-52. PubMed ID: 19932000
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
[TBL] [Abstract][Full Text] [Related]
16. [Diffusion weighted whole body imaging with background body signal suppression (DWIBS) in nodal metastasis of colorectal cancer].
Shuto K; Saito H; Ohira G; Miyauchi H; Matsubara H
Nihon Rinsho; 2011 Apr; 69 Suppl 3():315-9. PubMed ID: 22213976
[No Abstract] [Full Text] [Related]
17. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
[TBL] [Abstract][Full Text] [Related]
18. Potential role of whole-body diffusion magnetic resonance imaging in tumor staging for pregnant patients with cancer.
Mahajan A; Santhosh Kumar GV; Vaidya T; Thakur M; Desai S
Indian J Cancer; 2018; 55(4):417-418. PubMed ID: 30829283
[TBL] [Abstract][Full Text] [Related]
19. Whole-body diffusion-weighted MR imaging with fat suppression by using STIR: clinical utility for detection of primary malignancies in patients initially presented with metastasis.
Liang X; Congxin W; Yi Z; Jinwen H; Chuanfu L
Eur J Radiol; 2011 Sep; 79(3):359-62. PubMed ID: 20334989
[TBL] [Abstract][Full Text] [Related]
20. Recurrence and metastasis of lung cancer demonstrate decreased diffusion on diffusion-weighted magnetic resonance imaging.
Usuda K; Sagawa M; Motomo N; Ueno M; Tanaka M; Machida Y; Maeda S; Matoba M; Tonami H; Ueda Y; Sakuma T
Asian Pac J Cancer Prev; 2014; 15(16):6843-8. PubMed ID: 25169535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
